Publications by authors named "Caroline Germa"

Claim this Profile
A
A View on Drug Development for Cancer Prevention.
Andrew R Reynolds, Michele Moschetta, Alula R Yohannes, Farzana Walcott, Marianne Ashford, Caroline Germa

Cancer Discov· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab activity in previously treated patients who stopped durvalumab without disease progression.
Siddharth Sheth, Chen Gao, Nancy Mueller, Natasha Angra, Ashok Gupta, Caroline Germa

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations.
Tanay S Samant, Shyeilla Dhuria, Yasong Lu, Marc Laisney, Shu Yang, Caroline Germa

Clin Pharmacol Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Debu Tripathy, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Caroline Germa

Lancet Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Gabe S Sonke, Lowell L Hart, Mario Campone, Frans Erdkamp, Wolfgang Janni, Caroline Germa

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.
Joyce O'Shaughnessy, Katarina Petrakova, Gabe S Sonke, Pierfranco Conte, Carlos L Arteaga, Caroline Germa

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
Gabriel N Hortobagyi, Salomon M Stemmer, Howard A Burris, Yoon-Sim Yap, Gabe S Sonke, Caroline Germa

N Engl J Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design.
Cristian Massacesi, Emmanuelle Di Tomaso, Patrick Urban, Caroline Germa, Cornelia Quadt

Onco Targets Ther· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.
Cristina Saura, Jose A Garcia-Saenz, Binghe Xu, Wael Harb, Rebecca Moroose, Caroline Germa

J Clin Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer.
Miguel Martin, Jacques Bonneterre, Charles E Geyer, Yoshinori Ito, Jungsil Ro, Caroline Germa

Eur J Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule.
Elisabeth Quoix, Jean-Luc Breton, Alain Ducoloné, Bertrand Mennecier, Alain Depierre, Caroline Germa

Lung Cancer· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of irinotecan as a 3-week schedule in children with refractory or recurrent solid tumors.
Gilles Vassal, Francois Doz, Didier Frappaz, Karima Imadalou, Evelyn Sicard, Caroline Germa

J Clin Oncol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis